Cited by 1,339Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesDermatological and COVID-19 studies

Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments

Open access
Yong, Shin Jie·2021·Infectious Diseases

Published version of a preprint

Abstract

Long COVID or post-COVID-19 syndrome first gained widespread recognition among social support groups and later in scientific and medical communities. This illness is poorly understood as it affects COVID-19 survivors at all levels of disease severity, even younger adults, children, and those not hospitalized. While the precise definition of long COVID may be lacking, the most common symptoms reported in many studies are fatigue and dyspnoea that last for months after acute COVID-19. Other persistent symptoms may include cognitive and mental impairments, chest and joint pains, palpitations, myalgia, smell and taste dysfunctions, cough, headache, and gastrointestinal and cardiac issues. Presently, there is limited literature discussing the possible pathophysiology, risk factors, and treatments in long COVID, which the current review aims to address. In brief, long COVID may be driven by long-term tissue damage (e.g. lung, brain, and heart) and pathological inflammation (e.g. from viral persistence, immune dysregulation, and autoimmunity). The associated risk factors may include female sex, more than five early symptoms, early dyspnoea, prior psychiatric disorders, and specific biomarkers (e.g. D-dimer, CRP, and lymphocyte count), although more research is required to substantiate such risk factors. While preliminary evidence suggests that personalized rehabilitation training may help certain long COVID cases, therapeutic drugs repurposed from other similar conditions, such as myalgic encephalomyelitis or chronic fatigue syndrome, postural orthostatic tachycardia syndrome, and mast cell activation syndrome, also hold potential. In sum, this review hopes to provide the current understanding of what is known about long COVID.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/23744235.2021.1924397

Cites

201 of 201 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Long COVID syndrome and its mechanisms are still poorly understood, and it affects people regardless of COVID-19 severity, including younger adults, children, and non-hospitalised people.

    “This syndrome and its underlying mechanisms are still poorly understood, as it affects people regardless of the severity of their COVID-19 infection, including younger adults, children, and those who were not hospitalised.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. [41]van den Borst B, et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis. 2020;ciaa1750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. [66]Krishna R, Chapman K, Ullah S.. 2020. 'Idiopathic Pulmonary Fibrosis', StatPearls (Treasure Island (FL)). [Google Scholar]

Cited by

Sorted by citations

Authors
Yong, S. J.
Affiliations
Sunway University (MY)
Corresponding author
Yong, Shin Jie
Venue
Infectious Diseases
Published
2021-05-22
Volume
53
Issue
10
Pages
737-754
ISSN
  • 0036-5548 (ISSN-L)
  • 2374-4235
  • 2374-4243
OpenAlex
W3165449608
Cited by
1,339
References
201
Citations by year
2026: 82 · 2025: 175 · 2024: 295 · 2023: 375 · 2022: 347 · 2021: 65
FWCI
34.71
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Scandinavian Journal of Infectious Diseases (publishedVersion)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • Figshare (cc-by)
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
Keywords
long COVID, pathophysiology, risk factors, treatment, fatigue, dyspnea, cognitive impairment, viral persistence, immune dysregulation, autoimmunity, D-dimer, C-reactive protein, lymphocyte count, rehabilitation, drug repurposing, chronic fatigue syndrome, postural orthostatic tachycardia syndrome, mast cell activation syndrome
MeSH terms
COVID-19, SARS-CoV-2, Post-Acute COVID-19 Syndrome, Mental Disorders, Female, Humans, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review